Race-ethnicity as an effect modifier of the association between HbAlc and mortality in U.S. adults without diagnosed diabetes

European Journal of Endocrinology

Volumn 165, Issue 2, 2011, Pages 275-281

  Kehl, Katharina G ^a   Findeisen, Hannes M ^b   Fardo, David W ^a,c   Bruemmer, Dennis ^b   Mannino, David M ^a   Sanderson, Wayne T ^a  

^a UNIVERSITY OF KENTUCKY COLLEGE OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; AMERICAN; ARTICLE; CARDIOVASCULAR DISEASE; CAUCASIAN; CAUSE OF DEATH; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; ETHNIC DIFFERENCE; ETHNIC GROUP; ETHNICITY; HEMOGLOBIN DETERMINATION; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MEXICAN; MORTALITY; NEGRO; PRIORITY JOURNAL; RACE; RACE DIFFERENCE; UNITED STATES; FEMALE; HEALTH SURVEY; MALE; RISK FACTOR; SENSITIVITY ANALYSIS; AGED; BLOOD; EQUIPMENT; ETHNOLOGY; MIDDLE AGED; PHYSIOLOGY; STATISTICS;

ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; CONTINENTAL POPULATION GROUPS; DIABETES COMPLICATIONS; DIABETES MELLITUS; EFFECT MODIFIERS (EPIDEMIOLOGY); ETHNIC GROUPS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; UNITED STATES; YOUNG ADULT;

EID: 79960180849     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-11-0171     Document Type: Article

References (25)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine 1993 329 977-986. (doi:10.1056/NEJM199309303291401)
2. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998 352 837-853. (doi:10.1016/S0140-6736(98)07019-6)
3. The International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009 32 1327-1334. (doi:10.2337/dc09-9033)
4. Selvin E, Crainiceanu CM, Brancati FL & Coresh J. Short-term variability in measures of glycemia and implications for the classification of diabetes. Archives of Internal Medicine 2007 167 1545-1551. (doi:10.1001/ archinte.167.14.1545)
5. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010 33 (Supplement 1) S62-S69. (doi:10.2337/dc10-S062)
6. Brewer N, Wright CS, Travier N, Cunningham CW, Hornell J, Pearce N & Jeffreys M. A New Zealand linkage study examining the associations between A1C concentration and mortality. Diabetes Care 2008 31 1144-1149. (doi:10.2337/dc07-2374)
7. Saydah S, Tao M, Imperatore G & Gregg E. GHb level and subsequent mortality among adults in the U.S. Diabetes Care 2009 32 1440-1446. (doi:10.2337/dc09-0117)
8. Khaw KT, Wareham N, Bingham S, Luben R, Welch A & Day N. Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. Annals of Internal Medicine 2004 141 413-420.
9. Selvin E, Steffes MW, Zhu H, Matsushita K, Wagenknecht L, Pankow J, Coresh J & Brancati FL. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. New England Journal of Medicine 2010 362 800-811. (doi:10.1056/NEJMoa0908359)
10. Riddle MC, Ambrosius WT, Brillon DJ, Buse JB, Byington RP, Cohen RM, Goff DC Jr, Malozowski S, Margolis KL, Probstfield JL, Schnall A & Seaquist ER. Epidemiologic relationships between A1C and all-cause mortality during a median 3.4-year follow-up of glycemic treatment in the ACCORD trial. Diabetes Care 2010 33 983-990. (doi:10.2337/dc09-1278)
11. Cohen RM. A1C: does one size fit all? Diabetes Care 2007 30 2756-2758. (doi:10.2337/dc07-1301)
12. Ziemer DC, Kolm P, Weintraub WS, Vaccarino V, Rhee MK, Twombly JG, Narayan KM, Koch DD & Phillips LS. Glucose-independent, black-white differences in hemoglobin A1c levels: a cross-sectional analysis of 2 studies. Annals of Internal Medicine 2010 152 770-777.
13. Herman WH, Dungan KM, Wolffenbuttel BH, Buse JB, Fahrbach JL, Jiang H & Martin S. Racial and ethnic differences in mean plasma glucose, hemoglobin A1c, and 1,5-anhydroglucitol in over 2000 patients with type 2 diabetes. Journal of Clinical Endocrinology and Metabolism 2009 94 1689-1694. (doi:10.1210/jc.2008-1940)
14. Herman WH, Ma Y, Uwaifo G, Haffner S, Kahn SE, Horton ES, Lachin JM, Montez MG, Brenneman T & Barrett-Connor E. Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program. Diabetes Care 2007 30 2453-2457. (doi:10.2337/dc06-2003)
15. Kirk JK, D'Agostino RB Jr, Bell RA, Passmore LV, Bonds DE, Karter AJ & Narayan KM. Disparities in HbA1c levels between African-American and non-Hispanic white adults with diabetes: a meta-analysis. Diabetes Care 2006 29 2130-2136. (doi:10.2337/dc05-1973)
16. Kirk JK, Passmore LV, Bell RA, Narayan KM, D'Agostino RB Jr, Arcury TA & Quandt SA. Disparities in A1C levels between Hispanic and non-Hispanic white adults with diabetes: a meta-analysis. Diabetes Care 2008 31 240-246. (doi:10.2337/dc07-0382)
17. Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-94. Series 1: programs and collection procedures. Vital and Health Statistics 1994 32 1-407.
18. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults - The Evidence Report. National Institutes of Health. Obesity Research 1998 6 (Supplement 2) 51S-209S.
19. NHANES III second laboratory data file documentation. In Third National Health and Nutrition Examination Survey (NHANES III), 1988-94. CDC, 1998.
20. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF III, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T & Coresh J. A new equation to estimate glomerular filtration rate. Annals of Internal Medicine 2009 150 604-612.
21. Warram JH, Gearin G, Laffel L & Krolewski AS. Effect of duration of type I diabetes on the prevalence of stages of diabetic nephropathy defined by urinary albumin/creatinine ratio. Journal of the American Society of Nephrology 1996 7 930-937. (Pubitemid 27465988)
22. Cefalu WT. Translating "Nondiabetic" A1C levels to clinical practice: the art of medicine. Diabetes 2010 59 1868-1869. (doi:10.2337/db10- 0800)
23. Gary TL, McGuire M, McCauley J & Brancati FL. Racial comparisons of health care and glycemic control for African American and white diabetic adults in an urban managed care organization. Disease Management: DM 2004 7 25-34. (doi:10.1089/109350704322918970)
24. Wisdom K, Fryzek JP, Havstad SL, Anderson RM, Dreiling MC & Tilley BC. Comparison of laboratory test frequency and test results between African-Americans and Caucasians with diabetes: opportunity for improvement. Findings from a large urban health maintenance organization. Diabetes Care 1997 20 971-977. (doi:10.2337/diacare.20.6.971)
25. Shilo S, Berezovsky S, Friedlander Y & Sonnenblick M. Hypoglycemia in hospitalized nondiabetic older patients. Journal of the American Geriatrics Society 1998 46 978-982. (Pubitemid 28374076)